Incorporating new criteria can improve the ability of CEUS LI-RADS to differentiate HCC from non-HCC malignancies
Rong Wen1, Yuting Peng1,2, Ruizhi Gao1
1Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Insights
A new criterion for early washout in contrast-enhanced ultrasound (CEUS) LI-RADS can improve the differentiation of hepatocellular carcinoma (HCC) from other liver malignancies. This modification enhances diagnostic accuracy for high-risk patients.
Area of Science:
- Hepatobiliary imaging
- Diagnostic radiology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) diagnosis relies on imaging.
- Contrast-enhanced ultrasound (CEUS) with LI-RADS criteria is crucial for HCC risk stratification.
- Distinguishing HCC from other malignant liver lesions can be challenging.
Purpose of the Study:
- To evaluate the diagnostic performance of CEUS LI-RADS.
- To enhance the differentiation between HCC and non-HCC malignancies by modifying LR-M criteria.
Main Methods:
- Retrospective analysis of CEUS examinations in high-risk HCC patients.
- Reassessment of LR-M lesions using modified criteria, focusing on early washout timing.
- Comparison of diagnostic efficacy across four distinct early washout criteria.
Main Results:
- Modified criteria, particularly 'washout onset-enhancement onset < 30 s' (Criterion 4), showed improved sensitivity for HCC detection compared to earlier criteria.
- Specificities and positive predictive values (PPVs) remained high across most modified criteria, with Criterion 1 showing the highest specificity.
- Criterion 2 demonstrated higher sensitivity but significantly lower specificity and PPV.
Conclusions:
- The proposed new criterion for early washout (washout onset-enhancement onset < 30 s) shows promise for improving HCC differentiation.
- Refining CEUS LI-RADS criteria can enhance diagnostic accuracy in distinguishing HCC from non-HCC malignancies.
- Further validation of modified LR-M criteria is warranted for clinical application.
Purpose:
This work aimed to evaluate the diagnostic performance of the CEUS LI-RADS and to further improve its ability to differentiate HCC from non-HCC malignancies by modifying the LR-M criteria.
Methods:
This retrospective study included patients with a high risk of HCC who underwent CEUS examination. A subgroup of LR-M lesions was reassessed by applying different diagnostic criteria, including Criterion 1: early washout < 60 s; Criterion 2: Criterion 1 + marked washout within 4 min; Criterion 3: early washout < 45 s; Criterion 4: washout onset-enhancement onset < 30 s. Diagnostic efficacy was assessed.
Results:
A total of 1681 liver lesions were included. When LR-5 was used as a predictor of HCC, the sensitivities of Criterion 2 (84.3%), Criterion 3 (73.1%), and Criterion 4 (73.5%) were greater than that of Criterion 1 (67.3%; all p < 0.01). The specificities of Criterion 1 (95.1%), Criterion 3 (94.2%), and Criterion 4 (94.6%) were similar and surpassed that of Criterion 2 (73.5%; all p < 0.01). The PPVs of Criterion 1 (97.7%), Criterion 3 (97.5%), and Criterion 4 (97.7%) were similar and surpassed that of Criterion 2 (95.7%; all p < 0.05).
Conclusion:
The use of the washout onset time minus the enhancement onset time < 30 s as a new criterion for early washout could help improve the differential ability for HCC and non-HCC malignancies.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
